Powering the Next Wave of Precision Genetic Medicines — Together
Our goal is to maximize the potential of our SORT LNP delivery technology even beyond those rare diseases in our pipeline so that more patients may realize the full benefit of genetic medicines.
We believe in winning together and importantly, winning in our shared mission to help more patients in need. Together, we can power the next wave of precision genetic medicines.
“We can enhance the potency of any genetic cargo by packaging it using our SORT LNP platform and delivering it directly to the organs and cells impacted by disease. This creates vast opportunities to address a wide range of unmet medical needs not possible with current technologies.”
Shehnaaz Suliman, M.D., M.B.A., M.Phil.
Chief Executive Officer

Strategic Investment from the Cystic Fibrosis Foundation
ReCode receives strategic investment from the Cystic Fibrosis Foundation of up to $15 million to support preclinical studies needed for an Investigational New Drug (IND) application and early clinical development of ReCode’s CFTR mRNA therapy for cystic fibrosis.

Strategic Collaboration Explores Single Vector Gene-Editing Platform
ReCode signs multi-year research collaboration and option agreement with AskBio which will combine ReCode’s SORT LNP technology with AskBio’s gene editing and DNA cargoes to potentially discover precision genetic medicines for the liver and lung.
Events & Presentations
September 11, 2023
September 14, 2023
|
New York
Morgan Stanley Annual Global Healthcare Conference
We’re excited to participate in the Morgan Stanley Annual Global Healthcare Conference in New York. This event is a key gathering of healthcare professionals and innovators from around the globe.
September 13, 2023
September 15, 2023
|
Boston, MA
September 26, 2023
September 26, 2023
|
Virtual
BMO BioPharma Spotlight Series: Latest Advances in Genome/Epigenome Editing
ReCode leadership will provide updates on our PCD and CF programs as well as our selective organ targeting (SORT) platform.
September 26, 2023
September 27, 2023
|
New York City, NY
Jefferies Cell & Genetic Medicine Summit
Our leadership team is looking forward to attending and presenting at the Jefferies Cell & Genetic Medicine Summit and sharing details of our progress advancing the next wave of precision genetic medicines.
Do you want to be on the frontier of a new generation of precision genetic medicines?
Contact us at [email protected]